No profile data available.
Rosetta Genomics Ltd. (ROSGQ) is a healthcare company in the additional medical testing equipment industry, based in Rehovot, Israel, with about 86 full-time employees.
It reported revenue of $9.23 million for fiscal year 2016, up 11.7% from fiscal year 2015, and net income of -$16.23 million. In Q2 2017 (the quarter ended June 30, 2017) revenue was $870,000, up 115.3% from a year before. Its market capitalization was $592 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2016; market data as of October 8, 2026.
Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide.
Rosetta Genomics reported $9.23 million in revenue for fiscal year 2016, up 11.7% from $8.27 million in fiscal year 2015. In Q2 2017 revenue was $870,000.
$592 as of October 8, 2026.
Listed companies of a similar size in the same industry (additional medical testing equipment) include Cyclo3pss Corporation (CYPS), Integrative Health Technologies, Inc. (IHTI), Response Genetics, Inc (RGDXQ), Biocept, Inc. (BIOCQ).